Dualalms Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $30K
Latest Deal Amount
  • Investors
  • 1

Dualalms General Information

Description

Developer of a nebulized agent prior to Laryngoscopic examinations. The company delivers nebulized agents prior to Laryngoscopic examinations to eliminate the common discomfort and complications that occur from the exam.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • Dallas, TX
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dualalms Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 26-Aug-2015 $30K 0000 Completed Startup
To view Dualalms’s complete valuation and funding history, request access »

Dualalms Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Health Wildcatters Accelerator/Incubator Minority 000 0000 000000 0
To view Dualalms’s complete investors history, request access »